TOKYO, Mar 18, 2021 – (JCN Newswire) – Fujitsu at the moment introduced it has concluded a complete collaborative analysis settlement with Nationwide Most cancers Middle Japan. The joint analysis will heart on exploring ways in which real-world information(1), together with medical data from digital information, might be leveraged to contribute to the event of recent medicine, scientific trials, and preventive drugs in pharmaceutical firms.
By its joint analysis with the Nationwide Most cancers Middle, Fujitsu goals to create new worth via a variety of data and evaluation providers by creating an anonymized private well being document scheme(2) (PHR), which incorporates case examine data and well being data on sufferers visiting the Nationwide Most cancers Middle Hospital East. Fujitsu moreover seeks to create a platform for offering pharmaceutical firms with information that can be utilized for drug improvement and preventive drugs. Fujitsu will set up a brand new mannequin to course of medical data from digital medical information into extremely safe statistical information to enhance the effectivity of scientific trials and helps lively participation in worldwide joint scientific trials by selling the variation of scientific trial information in Japan to world requirements.(3)
With a watch to contributing to the wellbeing of individuals in society, Fujitsu will work to enhance the event pace and high quality of prescription drugs and different merchandise that promote the well being of shoppers. In flip, Fujitsu will play a task in resolving points such because the time required for scientific trials and prices, create quite a lot of providers that contribute to areas similar to preventive drugs and individualized most cancers drugs, and implement these providers by the top of fiscal 2021.
Lately, real-world information has been attracting elevated consideration within the healthcare discipline, and it’s starting for use in a variety of fields globally–from drug approval functions to the event of medical gadgets and preventive drugs. Quite a lot of totally different information varieties are getting used to those ends, starting from affected person digital medical document data and medical examination data, to day by day measurement information similar to weight and physique composition displays(4), in addition to important data similar to temperature and blood strain that may be obtained from sensible gadgets.
Regardless of the potential for such information, nevertheless, challenges stay round extracting helpful data from unstructured sources like medical doctors’ notes, and so forth., and it has develop into essential to develop new platforms and information extraction applied sciences to successfully and securely streamline the usage of helpful medical information. To this finish, Fujitsu has concluded a complete settlement with the Nationwide Most cancers Middle with the last word objective of contributing to the speedy improvement of prescription drugs and scientific trials by pharmaceutical firms that promote the well being of shoppers and can begin joint analysis on this discipline.
In regards to the Joint Analysis
In collaboration with the Nationwide Most cancers Middle, Fujitsu is implementing three initiatives to make the most of real-world information on the Nationwide Most cancers Middle Hospital East.
Verification of utilization of real-world information (real-world information share)
– Along with medical data from the digital medical document techniques, which has been troublesome to make use of till now, data on case research and knowledge on the well being of native sufferers (PHR) is processed right into a format that’s straightforward for pharmaceutical firms to deal with and offered as safe, high-quality information. The effectiveness of utilizing real-world information in growing new AI applied sciences to assist diagnoses and therapy may also be verified.
Institution and validation of recent scientific trial service fashions (DX for Medical Trial Operations)
– Pure language evaluation know-how can be utilized to the evaluation of medical data within the digital medical document system as a way to set up a brand new scientific trial service mannequin that may routinely determine applicable scientific trial sufferers with overwhelming pace and accuracy. This course of is presently carried out manually on the subject of medical data within the digital medical document system (scientific trial affected person recruitment). By this examine, the effectiveness of the system in considerably lowering the price and period of scientific trials, together with bettering the effectivity of in-hospital operations can be verified.
– Fujitsu will promote efforts to adapt scientific trial information in Japan to world requirements and assist lively participation in worldwide scientific trials.
Institution of a platform for protected and safe use of medical information (widespread platform)
– With the intention to perform these two verifications, Fujitsu will develop a platform that may safely and securely make the most of medical information by changing medical data recorded as textual content information within the digital medical document system right into a format that may be utilized as information. This platform makes use of know-how developed by Fujitsu Laboratories, Ltd., in addition to information extraction know-how that’s being newly developed.
2. Function of Fujitsu, Nationwide Most cancers Middle
– Improvement of applied sciences and platforms wanted to make the most of real-world information
– Verifying streamlining of scientific trial operations with affected person recruiting perform
– Coordination with nationwide insurance policies for the utilization of PHRs (5)
Nationwide Most cancers Middle
– Provision of medical information at Nationwide Most cancers Middle Hospital East
– Provision of know-how on scientific apply, scientific analysis, and scientific trials
– Verification of the contents of joint analysis
3. Interval of Joint Analysis
March 16, 2021 ~ March 31, 2023
Nationwide Most cancers Middle Hospital East and Exploratory Oncology Analysis & Medical Trial Middle
Sooner or later, Fujitsu won’t solely collaborate with pharmaceutical firms, but additionally take into account working with numerous firms that present wellbeing-related services to shoppers in Japan and all through the world. Based mostly on the outcomes of this joint analysis, by the top of fiscal 2021 Fujitsu will develop platforms and providers that allow the protected and safe use of real-world information and supply wellbeing to shoppers. By the availability of those platforms and providers to pharmaceutical firms, Fujitsu goals to contribute to the streamlining of drug improvement and scientific trials.
(1) real-world information：
Information generated by day by day medical care and private well being administration.
A system by which people accumulate and handle their very own medical data and different health-related data. Refers to data that may be topic to disclosure management on the discretion of the person.
(3) worldwide joint scientific trials：
A scientific trial carried out concurrently in a number of international locations or areas.
(4) weight and physique composition displays：
a measuring instrument that measures weight and physique fats share and visceral fats ranges and so forth.
(5) Nationwide insurance policies:
For instance, insurance policies led by Information Well being Reform Promotion Headquarters of the Ministry of Well being, Labour and Welfare similar to “Well being, Medical, and Nursing Care Data Utilization Research Group”.
Fujitsu is the main Japanese data and communication know-how (ICT) firm providing a full vary of know-how merchandise, options and providers. Roughly 130,000 Fujitsu individuals assist prospects in additional than 100 international locations. We use our expertise and the ability of ICT to form the way forward for society with our prospects. Fujitsu Restricted (TSE:6702) reported consolidated revenues of three.9 trillion yen (US$35 billion) for the fiscal yr ended March 31, 2020. For extra data, please see www.fujitsu.com.
Copyright 2021 JCN Newswire. All rights reserved. www.jcnnewswire.com